Effects of Maternal Health During Pregnancy and Child Immunization on Mother-to-Child Transmission of Hepatitis B Virus: A Multicentre, Large-Sample Study in Southeast China
Xin-Xin Huang,Quan Lin,Yun Li,Li Li
DOI: https://doi.org/10.2147/idr.s443172
2024-03-14
Infection and Drug Resistance
Abstract:Xin-Xin Huang, 1 Quan Lin, 2 Yun Li, 2 Li Li 2 1 The Ministry of Health, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China; 2 Department of Obstetrics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China Correspondence: Li Li, Email Purpose: High hepatitis B infection rates in China are a major public health issue, and mother-to-child transmission (MTCT) is a significant risk factor. Patients and Methods: This study was conducted with a prospective multicentre design from January 2021 to December 2022 in 245 hospitals providing midwifery services in southeastern China. The participants were pregnant women who were positive for hepatitis B surface antigen (HBs Ag) and their children. The HBs Ag concentration was tested in children aged 8– 12 months. The odds ratio for each risk factor was calculated by logistic regression analysis, and the decision tree model was used. Results: A total of 5369 children born to hepatitis B-infected mothers between 8 and 12 months of age were enrolled, among whom 81 (1.51%) were positive for HBsAg. The risk factors for hepatitis B infection in 5369 children under one-year-old were a high intrauterine hepatitis B exposure level, a history of hepatitis B immunoglobulin (HBIG) delay beyond 12 hours after birth, and lack of full hepatitis B vaccine (HepB), with risks of 3.356 (1.223~9.209), 5.691 (1.931~16.773), and 5.137 (2.265~11.650), respectively. The discrimination accuracy of the decision tree was 98.5%. The risk factors for hepatitis B infection in 4542 children under one year old with high exposure risk were nonstandard treatment by the mother during pregnancy, HBIG delay beyond 12 hours after birth, and no complete HepB administration, with risks of 2.925 (1.063– 8.047), 5.354 (1.806– 15.871) and 5.147 (2.258– 11.733), respectively. The discrimination accuracy of the decision tree was 98.3%. Conclusion: To prevent mother-to-child transmission of hepatitis B, it is necessary to standardize the treatment of pregnant women with a high exposure risk of hepatitis B, implement combined vaccination within 12 hours of birth, and standardise the full course of HepB. Keywords: hepatitis B, prevention of mother-to-child transmission, risk factors, risk of exposure, decision tree Hepatitis B virus (HBV) infection is one of the world's most serious public health problems. A total of 296 million people are chronically infected with HBV. 1 During the perinatal period, HBV is mainly transmitted to infants through the mother's blood and body fluids. 2 Without intervention, 70–90% of infants born to mothers positive for hepatitis B antigen will develop chronic infection. 3 The Global Burden of Disease study found that, in contrast to the overall trend of a decreasing burden of other infectious diseases, disability-adjusted life-years (DALYs) due to the long-term sequelae of chronic hepatitis B (CHB) are generally increasing. 4 A large proportion of those infected with the HBV are women of childbearing age. In countries with a high incidence of CHB (≥8%), the main routes of transmission are perinatal (>20%) and early childhood infection (>60%). 5 In the absence of vaccination, more than 50% of infections occur in childhood and adolescence, and more than 20% are due to perinatal morbidity associated with HBV infection. 6,7 Mother-to-child transmission (MTCT) is one of the leading causes of chronic hepatitis B infection and related mortality worldwide. 8 MTCT is responsible for 30–50% of HBV transmission in China. 2 Therefore, the prevention of MTCT and the elimination of the main transmission route of HBV are essential measures for the eradication of this disease. In 2016, the World Health Organization (WHO) launched the Global Health Sector Strategy on Viral Hepatitis 2016–2021, which focused on eliminating viral hepatitis as a significant public health threat by 2030. 9 The prevention of MTCT is one of the five core areas of this strategic plan, aimed at achieving a rate of <0.1% of HBV infection in children under five years of age. 9 China is set to play a vital role in achieving the global goal of eradicating hepatitis B by 2030. Routine vaccination is the most effective way to eliminate hepatitis B in newborns. 10 To prevent MTCT of hepatitis B and control the epidemic of hepatitis B, the WHO recommends hepatitis B vaccine (HepB) wi -Abstract Truncated-
pharmacology & pharmacy,infectious diseases